Back to search

Article

Heterologous third and fourth dose vaccine to reduce severity and mortality in COVID-19 patients during delta and omicron predominance: A cohort study in Chiang Mai, Thailand

2022-08-26

Abstract excerpt

<title>Abstract</title> <p>Background The Coronavirus disease 2019 (COVID-19) pandemic has evolved quickly, with numerous waves of different variants of concern resulting in the need for countries to offer continued protection through booster vaccinations. To ensure adequate coverage, Thailand has proactively adopted heterologous vaccination schedules. While studies have assessed homologous schedules in detail,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
57c5a9c0-9feb-5b37-a0a5-ab4d2d76b1f7
DOI
10.21203/rs.3.rs-1973470/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Heterologous third and fourth dose vaccine to reduce severity and mortality in COVID-19 patients during delta and omicron predominance: A cohort study in Chiang Mai, ThailandDOI 10.21203/rs.3.rs-1973470/v1
Effectiveness of heterologous 3rd and 4th dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand.Semantic proximity
Waning vaccine response to severe COVID-19 outcomes during omicron predominance in ThailandSemantic proximity
Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in ThailandSemantic proximity
Immunity response against mild-to-moderate breakthrough COVID-19Semantic proximity
Effectiveness of Coronavac and ChAdOx1 COVID-19 vaccines against severe illness in Thailand: A retrospective cohort studySemantic proximity
Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, December 2021 - May 2022Semantic proximity
Clinical Characteristics and Outcome of Patients with Sars-Cov-2 Omicron Variant in Shanghai: A Single Center, Retrospective, Observational StudySemantic proximity
Reported Effectiveness of COVID-19 Booster Vaccines: A Systematic Review of Early Literature and Implications for Emerging Vaccination PolicySemantic proximity
Facing the Omicron variant – How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic reviewSemantic proximity
Effectiveness of the Third mRNA Vaccine Dose Against COVID-19 During the Omicron Variant Dominant Period: A Systematic Review and Meta-AnalysisSemantic proximity
Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity
Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in FranceSemantic proximity
Select a neighboring publication to make it the new centre.